Written by Klarity Editorial Team
Published: Mar 22, 2026

If you’ve been lying awake at 3 a.m. wondering whether you can get help for your insomnia without leaving your bed, you’re not alone—and yes, you absolutely can. Telehealth has revolutionized how Americans access treatment for sleep disorders, making it possible to consult with licensed healthcare providers and receive prescriptions for insomnia medications entirely online.
But navigating the landscape of virtual sleep care isn’t always straightforward. Different states have different rules. Not all insomnia medications can be prescribed remotely. And understanding what’s legal, safe, and effective requires looking beyond the marketing promises of telehealth platforms.
This comprehensive guide will walk you through everything you need to know about accessing insomnia treatment through telehealth in 2025—from federal regulations and state-specific requirements to what medications you can expect and when you should see a doctor in person instead.
Telehealth for insomnia means connecting with a healthcare provider via video call, phone, or secure messaging platform to discuss your sleep difficulties and receive treatment recommendations. For many people struggling with chronic insomnia—defined as difficulty falling or staying asleep at least three nights per week for three months or longer—this approach offers a convenient, accessible path to care.
The good news? Non-controlled insomnia medications like trazodone and low-dose doxepin (Silenor) can legally be prescribed via telehealth in all 50 states, as long as the provider conducts an appropriate evaluation and establishes a legitimate patient-provider relationship.
Unlike controlled substances (which we’ll discuss later), these medications face no federal barriers to telemedicine prescribing. The Ryan Haight Act of 2008, which requires an in-person medical exam before prescribing controlled substances online, specifically applies only to Schedule II-V drugs—not to unscheduled medications commonly used for sleep.
Federal law doesn’t prevent doctors from prescribing non-controlled medications remotely. State laws govern the specifics of how telehealth must be conducted—requiring things like:
As of late 2025, the DEA has extended pandemic-era flexibilities for controlled substance prescribing through December 31, 2025, allowing even tightly regulated medications to be prescribed via telehealth under certain conditions. However, most telehealth platforms focusing on insomnia stick to non-controlled options to ensure consistent, legal access regardless of regulatory changes.
The Ryan Haight Online Pharmacy Consumer Protection Act was enacted in 2008 following the tragic death of a teenager who obtained controlled medications online without proper oversight. The law requires healthcare providers to conduct an in-person medical evaluation before prescribing controlled substances (Schedule II-V drugs) via the internet—with limited exceptions.
Here’s what this means for insomnia treatment:
For non-controlled medications (like trazodone or doxepin), the Ryan Haight Act does not apply. There is no federal requirement for an in-person exam before prescribing these medications through telehealth.
For controlled sleep medications (like zolpidem/Ambien, eszopiclone/Lunesta, or temazepam), the normal rule would require an in-person visit. However, during the COVID-19 public health emergency, the DEA waived this requirement—and has continued extending that waiver. As of November 2024, the DEA and HHS announced a third extension of telehealth prescribing flexibilities through December 31, 2025.
This means controlled substance prescribing for insomnia is technically allowed via telehealth right now, but the rules could change in 2026. Many responsible telehealth providers avoid controlled sleep medications altogether due to abuse potential and regulatory uncertainty, focusing instead on safer, non-controlled alternatives.
The DEA is expected to finalize new telemedicine regulations sometime in 2025 or 2026. These rules may:
For now, telehealth providers and patients should stay informed about potential changes—but for non-controlled insomnia medications, access is expected to remain stable.
While federal law sets the floor, each state adds its own requirements for telehealth practice. Here’s what you need to know about some of the most populous states:
Telehealth allowed? Yes ✅
In-person exam required? No—a telehealth consultation satisfies California’s ‘good faith exam’ standard for prescribing.
Recent changes: California is considering AB 1503, which would explicitly allow asynchronous (questionnaire-based) evaluations for certain prescriptions. As of December 2025, this bill hasn’t become law yet, but California already permits video-based exams for insomnia medications.
Provider scope: Nurse practitioners in California are transitioning to independent practice authority. Under AB 890, qualified NPs can practice without physician supervision after meeting experience requirements (implementation ongoing through 2026).
Telehealth allowed? Yes ✅
In-person exam required? No—Texas permits telemedicine prescribing for new patients if the standard of care is met. Video consultations are typically used for initial evaluations.
Special notes: Texas requires two-way audio/video for prescribing in certain situations (like chronic pain management), but for straightforward insomnia cases, a thorough telehealth exam suffices. NPs and PAs in Texas work under collaborative agreements with physicians but can prescribe non-controlled medications in any setting.
Telehealth allowed? Yes ✅
In-person exam required? No—Florida law explicitly states that a telehealth consultation can serve as the medical evaluation prior to prescribing.
Controlled substance note: Florida bans telehealth prescribing of Schedule II controlled substances except for psychiatric care, inpatient settings, hospice, and nursing home patients. This doesn’t affect non-controlled insomnia medications like trazodone.
Provider scope: Most APRNs in Florida work under physician protocols, though some with specific credentials have been granted independent primary care authority since 2020.
Telehealth allowed? Yes ✅
In-person exam required? Not for non-controlled medications. New York finalized rules in May 2025 that mirror the DEA’s proposed 30-day limit for controlled substances prescribed via telehealth without an in-person exam—but this doesn’t affect medications like trazodone or doxepin.
Provider scope: NPs in New York can practice independently after completing 3,600 hours of supervised practice. PAs require ongoing physician supervision.
Telehealth allowed? Yes ✅
In-person exam required? No—New Hampshire’s SB 252 (effective August 2025) explicitly removed the prior in-person exam requirement for teleprescribing. Providers must conduct appropriate follow-ups at least annually for ongoing treatment.
Provider scope: New Hampshire grants full practice authority to NPs; PAs work collaboratively with physicians.
Telehealth allowed? Yes ✅
In-person exam required? Periodically—Alabama requires that after four telehealth visits for the same condition within one year, patients must be referred for an in-person evaluation within 12 months.
Provider scope: NPs and PAs work under physician supervision in Alabama and cannot prescribe Schedule II controlled substances.
Trazodone
Doxepin (Low-Dose/Silenor)
Both medications can be prescribed with refills (up to 12 months in many cases), though responsible providers typically require periodic check-ins every 2-3 months to monitor progress and adjust treatment.
Zolpidem (Ambien), Eszopiclone (Lunesta), Zaleplon (Sonata)
Benzodiazepines (Temazepam, Triazolam)
Reputable telehealth platforms like Klarity Health typically focus on non-controlled options for initial treatment, reserving controlled substances for cases where they’re already established or when patients can be appropriately monitored. This approach ensures continuity of care regardless of regulatory changes and prioritizes patient safety.
When you connect with a telehealth provider for insomnia, expect a thorough evaluation that mirrors what would happen in an office visit:
Medical history review:
Sleep diary: Many providers ask you to track your sleep for 1-2 weeks before the consultation—noting bedtimes, wake times, sleep quality, and factors that might affect sleep.
Screening questions: The provider will screen for conditions that require in-person evaluation, such as:
Lifestyle assessment: Expect questions about sleep hygiene—your bedroom environment, electronic device use, exercise habits, stress levels, and bedtime routines.
Based on your evaluation, the provider will develop a personalized treatment plan. Evidence-based insomnia treatment typically includes:
1. Cognitive Behavioral Therapy for Insomnia (CBT-I)
CBT-I is considered the gold-standard, first-line treatment for chronic insomnia. It involves:
Many telehealth platforms, including Klarity Health, integrate CBT-I into their treatment approach or partner with digital therapeutic tools and specialized sleep therapists.
2. Medication (When Appropriate)
Medications are typically used:
3. Sleep Hygiene Education
Your provider will discuss practical strategies:
Ongoing management is crucial for insomnia treatment. Telehealth makes this easier through:
Regular check-ins: Most platforms schedule follow-ups every 4-8 weeks initially, then extending to 3-month intervals once sleep improves.
Medication adjustments: Your provider may adjust dosing, try different medications, or taper you off medication as sleep improves.
Monitoring for side effects: Telehealth providers watch for medication side effects like morning grogginess, weight changes, or mood shifts.
Long-term strategy: The goal is usually to transition to minimal or no medication use while maintaining good sleep through behavioral strategies.
While telehealth works well for many people with insomnia, certain situations require in-person evaluation:
Seek immediate medical attention if you experience:
These symptoms could indicate serious underlying conditions like heart problems, severe sleep apnea, neurological disorders, or psychiatric emergencies that require immediate, comprehensive evaluation.
Sleep apnea: If you have loud snoring, gasping for air during sleep, observed breathing pauses, or severe daytime sleepiness, you likely need a sleep study. Untreated sleep apnea significantly increases risk for heart disease, stroke, and accidents. A telehealth provider can refer you for appropriate testing, but the diagnostic sleep study itself requires specialized equipment.
Complex psychiatric conditions: While telehealth psychiatry has expanded dramatically, initial evaluation for conditions like bipolar disorder, severe depression with psychotic features, or active substance use disorders typically benefits from in-person assessment—particularly if medication management will be complex.
Suspected neurological disorders: Conditions like narcolepsy, REM sleep behavior disorder, or parasomnias (sleepwalking, night terrors) often require in-person neurological examination and polysomnography.
Medical conditions needing examination: If your insomnia might be secondary to thyroid disease, chronic pain, or other medical conditions, lab work or physical examination may be needed to properly diagnose and treat the underlying cause.
Telehealth may not be suitable if:
Responsible telehealth providers will screen for these factors and refer you to appropriate in-person care when needed.
Physicians can prescribe any medication within their scope of practice via telehealth in all states, including both non-controlled and (under current temporary rules) controlled insomnia medications. They must be licensed in the state where the patient is located.
NPs are advanced practice registered nurses who can diagnose conditions and prescribe medications. Their authority varies significantly by state:
Full Practice Authority States (27 states as of 2025): NPs can evaluate, diagnose, and treat patients independently, including prescribing insomnia medications without physician oversight. Examples include New Hampshire, Delaware, Oregon, and (increasingly) California under AB 890.
Reduced Practice States: NPs require a collaborative agreement or supervision from a physician to prescribe. This includes large states like Texas, Georgia, and Florida. In these states, NPs working for telehealth platforms have physician partners who oversee prescribing protocols—but this doesn’t limit patient access; it’s an administrative requirement that happens behind the scenes.
All NPs nationwide can prescribe non-controlled insomnia medications like trazodone and doxepin under their state’s scope of practice rules (with appropriate supervision where required).
PAs work under the supervision of physicians in all states, though the level of supervision varies (some states allow PAs significant autonomy with general oversight rather than case-by-case review). PAs can prescribe non-controlled medications for insomnia in every state under their collaborative agreements.
Controlled substance prescribing by PAs is more restricted in some states—for instance, Texas PAs cannot prescribe Schedule II drugs outside hospital settings, and some states limit PA prescribing of any controlled substance.
When you use a telehealth platform for insomnia treatment, you might see any of these provider types. Platforms like Klarity Health employ a mix of psychiatrists, psychiatric nurse practitioners, and other qualified clinicians—all licensed in the states they serve.
You can receive the same quality of care from an experienced NP as from an MD for straightforward insomnia. What matters most is the provider’s training, experience with sleep disorders, and their commitment to evidence-based treatment.
Klarity Health ensures all providers are appropriately credentialed, follow current clinical guidelines, and can prescribe commonly used insomnia medications (including trazodone and doxepin) in compliance with state and federal regulations.
Yes, in most cases. Federal parity laws and state mandates require most insurance plans to cover telehealth visits at the same rate as in-person visits for the same service. This means:
Medicare has extended many telehealth flexibilities beyond the pandemic, though some geographic and originating site restrictions still exist for certain services. Medicare Advantage plans often have broader telehealth coverage.
Medicaid coverage varies by state, but most states now cover telehealth for behavioral health services including insomnia treatment.
Not everyone has insurance or wants to use it for mental health services. Many telehealth platforms offer transparent self-pay pricing:
Klarity Health accepts both insurance and cash pay, giving you flexibility. Their transparent pricing model means you know costs upfront—no surprise bills. For patients without insurance or with high-deductible plans, cash-pay can sometimes be more affordable than using insurance with a large deductible.
Non-controlled insomnia medications are generally affordable:
Trazodone (generic):
Doxepin/Silenor:
Both medications are on most insurance formularies. If cost is a concern, your telehealth provider can discuss the most affordable options.
Once your telehealth provider determines medication is appropriate, they’ll electronically send the prescription to your preferred pharmacy. Many states now require e-prescribing for all medications (not just controlled substances), making the process seamless:
Initial prescriptions: Providers typically start with a 30-day supply to assess how you respond to the medication and monitor for side effects.
Refills: Non-controlled medications can legally be prescribed with refills covering up to 12 months. In practice, your provider will likely:
Some states have additional rules:
Prescription Monitoring Programs (PMPs): While these databases track controlled substances, some states include all prescriptions. Providers may check your PMP history as part of their evaluation—this is for your safety, ensuring they know about all your medications to avoid dangerous interactions.
Periodic evaluations: States like Alabama require in-person evaluation after extended telehealth-only care (after four visits for the same issue). Your provider will discuss any such requirements if they apply to you.
Not all telehealth platforms are created equal. The rapid growth of virtual care has unfortunately included some services that prioritize convenience over safety. Here’s how to identify quality care:
❌ Prescribing without a real evaluation: Any service that issues prescriptions based solely on a brief questionnaire without a video or phone consultation is operating in a legal and ethical gray area.
❌ Prescribing controlled substances too readily: If a platform advertises easy access to Ambien, benzodiazepines, or other controlled substances as their main selling point, that’s concerning. Responsible providers use these medications sparingly.
❌ No licensed providers or unclear credentials: You should know exactly who your provider is, what their qualifications are, and where they’re licensed.
❌ No follow-up or monitoring: Legitimate care requires ongoing monitoring, not just a one-time prescription.
❌ Pressure to purchase: If you feel pressured to start medication or continue services you don’t need, that’s a red flag.
✅ Comprehensive initial evaluation: Look for platforms that spend 30+ minutes on initial consultations, take detailed histories, and discuss non-medication options.
✅ Evidence-based treatment: Quality providers emphasize behavioral interventions (CBT-I) alongside or instead of medication when appropriate.
✅ Clear provider credentials: You should easily find information about your provider’s license, training, and qualifications.
✅ Transparent pricing: Whether you’re using insurance or paying cash, costs should be clear upfront.
✅ Regular follow-up: Expect scheduled check-ins, not just PRN refills.
✅ Appropriate referrals: Good telehealth providers know when to refer you elsewhere—to sleep specialists, for in-person evaluation, or for conditions outside their scope.
Klarity Health has built its platform around these quality principles:
Provider availability: Klarity maintains a network of board-certified psychiatrists and psychiatric nurse practitioners across multiple states, ensuring you can see a qualified provider quickly—often within days, not weeks.
Transparent pricing: Whether you’re using insurance or self-pay, Klarity provides clear cost information before you book. No hidden fees or surprise bills.
Comprehensive care: Klarity’s providers take time for thorough evaluations, discuss both medication and behavioral strategies, and create personalized treatment plans.
Flexible payment options: Klarity accepts most major insurance plans and also offers competitive self-pay rates for those without coverage or who prefer not to use insurance.
Ongoing support: Klarity schedules regular follow-ups and makes it easy to message your provider between appointments with questions or concerns.
The platform’s focus on mental health conditions—including insomnia as part of broader mental health care—means their providers have specific expertise in sleep disorders and their relationship to anxiety, depression, and other psychiatric conditions.
The biggest question mark for 2026 is what the DEA will do about controlled substance prescribing. While this won’t affect non-controlled insomnia medications, it could impact access to medications like zolpidem or eszopiclone.
Possible scenarios:
Special telemedicine registration: Providers might need to register with the DEA specifically for telemedicine prescribing of controlled substances, with certain safeguards in place.
Modified in-person requirements: Some proposals would allow an initial 30-day controlled substance prescription via telehealth, with in-person evaluation required for continuation.
Permanent flexibilities: Congress could pass legislation making the current temporary rules permanent, recognizing telehealth’s value for access to care.
What won’t change: Non-controlled insomnia medications will remain accessible via telehealth. The regulatory uncertainty affects only controlled substances.
Several trends will likely improve telehealth access:
Interstate licensing compacts: More states are joining agreements that allow providers licensed in one state to practice in others more easily, expanding the pool of available providers.
Integration with in-person care: ‘Hybrid’ models combining telehealth convenience with occasional in-person visits are becoming more common, offering the best of both worlds.
Digital therapeutics: FDA-cleared apps and programs for CBT-I are becoming more sophisticated and integrated with telehealth platforms.
AI and remote monitoring: Sleep tracking technology and AI-assisted symptom monitoring may enhance telehealth providers’ ability to optimize treatment remotely.
Expect continued attention from regulators and medical boards on ensuring telehealth maintains the same standards as in-person care:
If you’ve been struggling with insomnia and putting off getting help because of the hassle of scheduling appointments, taking time off work, or finding a provider who’s accepting new patients, telehealth offers a genuine solution.
You can:
The key is choosing a reputable platform that prioritizes your safety and wellbeing over convenience alone.
Klarity Health provides exactly this kind of responsible, accessible care. Their providers are available across multiple states, accept both insurance and self-pay, and focus on comprehensive treatment that addresses the root causes of your sleep difficulties—not just symptom management.
Ready to finally get the sleep you need? Visit Klarity Health to schedule a consultation with a licensed provider who can evaluate your insomnia and create a personalized treatment plan. Better sleep may be closer than you think—and you don’t even have to get out of bed to start the process.
U.S. Drug Enforcement Administration. (2024, November 15). DEA and HHS extend telemedicine flexibilities through 2025. https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025
Sheppard Mullin Healthcare Team. (2025, August 15). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era prescribing rules. National Law Review. https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era
Center for Connected Health Policy. (2025, November). Online prescribing: State telehealth laws and policies. https://www.cchpca.org/topic/online-prescribing/
Morse, S. (2024, November 18). Telehealth prescribing of controlled drugs extended through 2025. Healthcare Finance News. https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025
MedX. (2024). Can telehealth prescribe sleeping pills? Navigating virtual insomnia treatment. https://medx.it.com/can-telehealth-prescribe-sleeping-pills-navigating-virtual-insomnia-treatment
Find the right provider for your needs — select your state to find expert care near you.